Literature DB >> 9293435

New aspects of podocyte cell biology.

P Mundel1, J Reiser.   

Abstract

Mesh：

Year:  1997        PMID： 9293435     DOI： 10.1159/000174136

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN： 1420-4096            Impact factor:   2.687


× No keyword cloud information.
  6 in total

1.  von Hippel-Lindau gene plays a role during zebrafish pronephros development.

Authors:  Yau-Hung Chen; Chiung-Fang Chang; Yen-Yu Lai; Chiao-Yin Sun; Yu-Ju Ding; Jen-Ning Tsai
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-21       Impact factor: 2.416

2.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

Authors:  Vera Eremina; Manish Sood; Jody Haigh; András Nagy; Ginette Lajoie; Napoleone Ferrara; Hans-Peter Gerber; Yamato Kikkawa; Jeffrey H Miner; Susan E Quaggin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin.

Authors:  Sonya D Coaxum; Maria N Garnovskaya; Monika Gooz; Aleksander Baldys; John R Raymond
Journal:  Biochim Biophys Acta       Date:  2009-03-31

4.  Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis.

Authors:  Darren J Bridgewater; Douglas G Matsell
Journal:  Pediatr Nephrol       Date:  2003-08-29       Impact factor: 3.714

5.  CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.

Authors:  Beina Teng; Patricia Schroder; Janina Müller-Deile; Heiko Schenk; Lynne Staggs; Irini Tossidou; Ivan Dikic; Hermann Haller; Mario Schiffer
Journal:  Diabetes       Date:  2016-08-16       Impact factor: 9.461

6.  The Extract of Litsea japonica Reduced the Development of Diabetic Nephropathy via the Inhibition of Advanced Glycation End Products Accumulation in db/db Mice.

Authors:  Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Kyuhyung Jo; So Dam Shin; Joo Hwan Kim; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-27       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.